Oscar Health Inc.

NYSE: OSCR · Real-Time Price · USD
15.64
0.96 (6.54%)
At close: Aug 15, 2025, 2:09 PM

Oscar Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10.73B 10.08B 9.18B 8.22B 7.23B 6.54B 5.86B 5.47B 5.05B 4.58B 4.13B 3.61B 3.05B 2.54B 1.92B 1.59B 1.26B 855.21M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
4.82B 10.08B 9.18B 8.22B 7.23B 6.54B 5.86B 5.47B 5.05B 4.58B 4.13B 3.61B 3.05B 2.54B 1.92B 1.59B 1.26B 855.21M
Operating Income
-139.36M 143.16M 33.43M 36.47M 24M -51.22M -267.3M -343.93M -474.31M -571.88M -610.08M -581.15M -598.07M -558.97M -571.08M -563.08M -431.13M -397.75M
Interest Income
n/a n/a n/a n/a 1.68M 1.68M 1.68M 1.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-151.33M 143.16M 33.43M 36.47M 24M -51.22M -267.3M -343.93M -474.31M -571.88M -610.08M -581.15M -598.07M -558.97M -571.08M -563.08M -431.13M -397.75M
Net Income
-161.23M 123.33M 25.43M 28.95M 18.15M -53.59M -270.73M -346.74M -474.26M -570.89M -606.27M -579.65M -598.22M -559.38M -573.11M -563.55M -431.21M -398.83M
Selling & General & Admin
1.94B 1.84B 1.76B 1.37B 1.24B 1.14B 1.15B 1.14B 889.18M 632.1M 309.78M 323.81M 305.26M 275.67M 265.58M 238.02M 214.56M 199.39M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
8.92B 8.09B 7.39B 6.81B 5.97B 5.44B 4.98B 4.68B 4.63B 4.52B 4.43B 3.87B 3.34B 2.83B 2.23B 1.91B 1.48B 1.05B
Operating Expenses
10.87B 9.94B 9.15B 8.18B 7.21B 6.59B 6.13B 5.81B 5.52B 5.16B 4.74B 4.19B 3.65B 3.1B 2.49B 2.15B 1.69B 1.25B
Interest Expense
23.68M 23.83M 23.73M 23.93M 24.24M 24.37M 24.6M 24.52M 24.52M 24.54M 22.62M 16.89M 11.16M 5.24M 4.72M 7.84M 7.44M 7.21M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.87B 9.94B 9.15B 8.18B 7.21B 6.59B 6.13B 5.81B 5.52B 5.16B 4.74B 4.19B 3.65B 3.1B 2.49B 2.15B 1.69B 1.25B
Income Tax Expense
9.33M 19.01M 7.3M 6.9M 5.74M 2.27M 3.29M 3.38M 855K -19K -523K 81K 1.1M 1.4M 846K 476K 75K 1.08M
Shares Outstanding (Basic)
253.42M 251.28M 240.39M 243.11M 238.67M 231.44M 227.08M 223.1M 219.4M 216.91M 215.19M 212.82M 211.31M 210.55M 209.78M 208.16M 207.48M 202.28M
Shares Outstanding (Diluted)
270.24M 305.94M 265.85M 243.11M 303.96M 293.8M 227.08M 223.1M 219.4M 216.91M 215.19M 212.82M 211.31M 210.55M 209.78M 208.16M 207.48M 205.31M
EPS (Basic)
-0.63 0.50 0.17 0.13 0.06 -0.25 -1.2 -1.59 -2.21 -2.67 -2.86 -2.76 -2.87 -2.69 -2.76 -2.77 -4.45 -5.5
EPS (Diluted)
-0.81 0.26 -0.06 -0.1 -0.17 -0.42 -1.2 -1.59 -2.21 -2.67 -2.86 -2.76 -2.87 -2.69 -2.75 -2.73 -2.1 -1.95
EBITDA
-97.08M 198.05M 89.31M 91.05M 80.58M 6.72M -212M -292.72M -428.23M -530.92M -572.17M -548.75M -571.81M -538.72M -551.76M -541.31M -410.48M -378.39M
EBIT
-130.44M 166.99M 57.16M 60.4M 48.23M -26.85M -242.7M -319.41M -449.79M -547.34M -587.45M -564.27M -586.91M -553.72M -566.36M -555.24M -423.69M -390.54M
Depreciation & Amortization
30.43M 31.06M 32.15M 30.65M 32.34M 33.57M 30.69M 26.69M 21.55M 16.42M 15.28M 15.52M 15.11M 15M 14.61M 13.93M 13.21M 12.14M